Aptevo Therapeutics Inc (NASDAQ: APVO)’s stock price has gone decline by -12.48 in comparison to its previous close of 1.13, however, the company has experienced a 40.07% increase in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-24 that Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Groupon (GRPN), Aptevo Therapeutics (APVO), NewJersey Resources (NJR), American Water Works (AWK) and Frontdoor (FTDR).
Is It Worth Investing in Aptevo Therapeutics Inc (NASDAQ: APVO) Right Now?
APVO has 36-month beta value of 5.28. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for APVO is 1.60M, and currently, short sellers hold a 9.10% ratio of that float. The average trading volume of APVO on May 06, 2024 was 814.08K shares.
APVO’s Market Performance
APVO stock saw a decrease of 40.07% in the past week, with a monthly decline of -71.25% and a quarterly a decrease of -85.95%. The volatility ratio for the week is 22.89%, and the volatility levels for the last 30 days are 16.74% for Aptevo Therapeutics Inc (APVO). The simple moving average for the past 20 days is -22.85% for APVO’s stock, with a -91.43% simple moving average for the past 200 days.
Analysts’ Opinion of APVO
Piper Jaffray, on the other hand, stated in their research note that they expect to see APVO reach a price target of $6. The rating they have provided for APVO stocks is “Overweight” according to the report published on October 05th, 2017.
APVO Trading at -72.90% from the 50-Day Moving Average
After a stumble in the market that brought APVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.78% of loss for the given period.
Volatility was left at 16.74%, however, over the last 30 days, the volatility rate increased by 22.89%, as shares sank -72.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -83.83% lower at present.
During the last 5 trading sessions, APVO rose by +40.07%, which changed the moving average for the period of 200-days by -97.46% in comparison to the 20-day moving average, which settled at $1.1499. In addition, Aptevo Therapeutics Inc saw -87.58% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APVO
The total capital return value is set at -1.64. Equity return is now at value -123.54, with -63.16 for asset returns.
Based on Aptevo Therapeutics Inc (APVO), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -2.17. The debt to equity ratio resting at 0.44. The interest coverage ratio of the stock is 3.01.
Currently, EBITDA for the company is -28.31 million with net debt to EBITDA at 0.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.64.
Conclusion
To put it simply, Aptevo Therapeutics Inc (APVO) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
